Similarly, miR-130 plays a role in tumor induction by reducing PTEN expression in various cancers, such as bladder cancer, invasive breast cancer, kidney cancer, gastric cancer, gliomas, lung cancer, and colon cancer. This evidence concerns the gene PTEN and urinary bladder carcinoma.